Enzyme Inhibitors
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) (NCT05288166) | Eli Lilly and Company | 2022-04-14 |
| Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals (NCT04340349) | Instituto Nacional de Rehabilitacion | 2021-02-01 |
| Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer (NCT04556071) | Xiaoxiang Chen | 2020-11-06 |
| Savolitinib vs. Sunitinib in MET-driven PRCC. (NCT03091192) | AstraZeneca | 2017-07-25 |
Track Enzyme Inhibitors automatically
Every clearance here is in the API, with alerts when new ones post.